# Evaluating the Immune Response for COVID-19

> **NCT04348422** · — · COMPLETED · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 214 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DIAGNOSTIC_TEST:** COVID-19 RT-PCR
- **DIAGNOSTIC_TEST:** COVID-19 Serology
- **OTHER:** Symptoms questionnare

## Key facts

- **NCT ID:** NCT04348422
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-01
- **Primary completion:** 2022-02-02
- **Final completion:** 2022-02-02
- **Target enrollment:** 214 (ACTUAL)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04348422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04348422, "Evaluating the Immune Response for COVID-19". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04348422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*